155 related articles for article (PubMed ID: 8112948)
1. Localized lepromatous leprosy and its response to chemo-immunotherapy.
Beena KR; Zaheer SA; Guleria I; Mukherjee R; Talwar GP; Mukherjee A; Ramesh V; Misra RS
Int J Dermatol; 1994 Jan; 33(1):64-7. PubMed ID: 8112948
[TBL] [Abstract][Full Text] [Related]
2. Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case report.
Zaheer SA; Suresh NR; Kar HK; Sharma AK; Mukherjee A; Mukherjee R; Talwar GP
Lepr Rev; 1991 Sep; 62(3):297-302. PubMed ID: 1795588
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
6. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy.
Zaheer SA; Mukherjee R; Ramkumar B; Misra RS; Sharma AK; Kar HK; Kaur H; Nair S; Mukherjee A; Talwar GP
J Infect Dis; 1993 Feb; 167(2):401-10. PubMed ID: 8421173
[TBL] [Abstract][Full Text] [Related]
7. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy: a report on hospital based immunotherapeutic clinical trials with a follow-up of 1-7 years after treatment.
Sharma P; Misra RS; Kar HK; Mukherjee A; Poricha D; Kaur H; Mukherjee R; Rani R
Lepr Rev; 2000 Jun; 71(2):179-92. PubMed ID: 10920613
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients.
Talwar GP; Zaheer SA; Mukherjee R; Walia R; Misra RS; Sharma AK; Kar HK; Mukherjee A; Parida SK; Suresh NR
Vaccine; 1990 Apr; 8(2):121-9. PubMed ID: 2336873
[TBL] [Abstract][Full Text] [Related]
12. Localized borderline lepromatous leprosy.
Jha PK; Talwar S; Suresh MS; Panvelkar V
Lepr Rev; 1991 Jun; 62(2):212-6. PubMed ID: 1870385
[TBL] [Abstract][Full Text] [Related]
13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
14. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports.
Lakshmi C; Srinivas CR
Int J Dermatol; 2014 Jan; 53(1):61-5. PubMed ID: 23675902
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.
Kamal R; Natrajan M; Katoch K; Arora M
Indian J Lepr; 2012; 84(4):287-306. PubMed ID: 23720894
[TBL] [Abstract][Full Text] [Related]
16. Comment: 'Immunological upgrading with combined immunotherapy and chemotherapy in a lepromatous leprosy patient: a case report'.
Sehgal VN; Bhattacharya SN; Jain S
Lepr Rev; 1992 Mar; 63(1):88-9. PubMed ID: 1569824
[No Abstract] [Full Text] [Related]
17. Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Lepr Rev; 2000 Jun; 71(2):193-205. PubMed ID: 10920614
[TBL] [Abstract][Full Text] [Related]
18. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
19. Sub-polar lepromatous leprosy localized to the face.
George M; Rajan U; George S; Pakran J; Thomas S
Dermatol Online J; 2010 Sep; 16(9):8. PubMed ID: 20875329
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]